Big Board Trading

[MiamiGent]

HNSN (NASDAQ) news yesterday:

... for Hansen Medical, CE mark allows us to initiate a selective commercial launch of our Magellan Robotic System in the large and rapidly expanding European Union peripheral vascular market. Once key initial sites are successfully up and running, we will commence full launch activities.

... peripheral vascular disease is unfortunatly huge- think coronary heart disease.
Chances are this or another such tool will be used on me someday... though I'm swimming like a fish and drinking red wine (not like a fish) to ward off that day!

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=65550916

O/S 54.6M

HNSN hit a 52 week high Monday at 5.28